ACE2 and COVID-19: Through genotyping of 550 patients, Möhlendick et al. (2021) demonstrated that the ACE2 polymorphism rs2285666 and also ACE2 rs2074192 [23] were implicated in a twofold increase in risk of SARS-CoV-2 infection and a threefold increase in COVID-19 severity and mortality.